Articles by Scott C. Henderson, MS
Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice
BySean Z. Zhao, MD, PhD,Thomas A. Burke, PharmD, MPH,Andrew Whelton, MD, PhD,Heather von Allmen,Scott C. Henderson, MS Blood Pressure Destabilization and Related Healthcare Utilization Among Hypertensive Patients Using Nonspecific NSAIDs and COX-2-Specific Inhibitors
BySean Z. Zhao, MD, PhD,Thomas A. Burke, PharmD, MPH,Andrew Whelton, MD, PhD,Heather von Allmen,Scott C. Henderson, MS Cost of Heart Failure Among Hypertensive Users of Nonspecific NSAIDs and COX-2-Specific Inhibitors
BySean Z. Zhao, MD, PhD,Thomas A. Burke, PharmD, MPH,Andrew Whelton, MD, PhD,Heather von Allmen,Scott C. Henderson, MS